Tatva Chintan (TATVA)
CyclicalFairStock Score: 24/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,717.3 |
| Market Cap | ₹4,017.12 Cr |
| P/E Ratio | 78.13 |
| ROCE | 1.2% |
| ROE | 4.32% |
| Dividend Yield | 0.06% |
| Profit Growth | 103.51% |
| Debt/Equity | 0.15 |
| Sales Growth | 36.35% |
| Promoter Holding | 72.02% |
| 52-Week Range | ₹1,044.1 — ₹2,109.95 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹334.03 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹1,311, Tatva Chintan demands a P/E of 87.34. That's a steep price for any company, let alone a specialty chemicals maker with a return on equity of just 4.32% and ROCE of 1.20%. In Graham's language, I'm being asked to pay nearly four and a half times book value for a business that earns little more than a fixed deposit on that book. The 52.89% sales growth catches the eye, and the 1000% profit growth looks spectacular until I realize it is from a small base. The latest quarter's net profit of ₹15 Cr on sales of ₹131 Cr — roughly 11.5% margin — is decent, but it still leaves an annualized earnings power that, at this market cap, leaves no margin of safety.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer